DUBLIN, Dec. 21, 2023 /PRNewswire/ — The “Europe Acute Care Syndromic Testing Market – Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering.
The Europe acute care syndromic testing market was valued at $0.90 billion in 2022 and is expected to reach $2.32 billion by 2033, growing at a CAGR of 8.95% between 2023 and 2033.
The increasing demand for early infectious illness identification has led to a notable surge in the acute care syndromic testing industry in Europe. The incidence of pandemics and the prevalence of infectious diseases have been major contributors to this rise. Furthermore, the expansion of the industry has been aided by the rise in global temperatures and the discovery of new infectious diseases in different places.
Promising healthcare solutions are available in the European acute care syndromic testing sector, and more developments may be possible. The acute care syndromic testing market is growing as a result of the advancement of instruments for early detection, treatment planning, diagnosis, and monitoring of infectious diseases.
The Europe market is witnessing increasing investments in healthcare infrastructure and the adoption of advanced diagnostic technologies, further boosting the growth of the acute care syndromic panel testing market. Additionally, favorable regulations and initiatives promoting the integration of syndromic panel testing in routine clinical.
Key Market Dynamics
Market Drivers
- Faster Results Acquired with Syndromic Tests
- Increasing Incidence of Infectious Diseases
- Overall Reduced Cost of Care Due to Early Diagnosis with Syndromic Testing
- Reduced Severe Adverse Effects from Pathogens
Market Challenges
- Need for Better Policies with Respect to Acute Care Syndromic Test Reimbursement
- Lack of High-Complexity Testing Centres
Market Opportunities
- Quick Access to Treatment and Reduced Use of Antibiotics
- High Number of Synergistic Activities and Mergers and Acquisitions (M&A) Over the Past Years
Key Market Players Profiles
- Biocartis
- bioMerieux
- DiaSorin
- Eurofins Scientific
- QIAGEN
- QuantuMDx Group
- Siemens Healthineers
Key Questions Answered in the Report
- What will be the growth rate of the Europe acute care syndromic testing market during the forecast period?
- What are the major market drivers, challenges, and opportunities in the Europe acute care syndromic testing market?
- What are the key development strategies that are being implemented by major players to sustain themselves in the competitive market?
- Who are the leading players with significant offerings in the acute care syndromic testing market?
Key Topics Covered:
1 Markets
1.1 Product Definition
1.3 Market Scope
1.3.1 Key Questions Answered in the Report
1.4 Research Methodology
2 Market Overview
2.1 Overview
2.2 Acute Care Syndromic Testing Workflow Analysis
2.3 Market Footprint and Growth Potential
2.4 Future Potential
3 Industry Insight
3.1 Stakeholder’s Perspective (N=20)
3.1.1 Physician’s Perception
3.1.2 Payor’s Perception
3.1.3 Investor’s Perception
3.2 Legal and Regulatory Framework of the Acute Care Syndromic Testing Market
3.2.1 Regulatory Framework in North America
3.2.2 Regulatory Framework in Europe
3.2.3 Regulatory Framework in Asia-Pacific
3.2.4 Regulatory Framework in Latin America
3.2.5 Regulatory Framework in Rest-of-the-World
3.3 Product Benchmarking
4 Market Dynamics
4.1 Overview
4.2 Impact Analysis
4.3 Market Drivers
4.4 Market Challenges
4.5 Market Opportunities
5 Europe
6 Company Profiles
- Biocartis
- bioMerieux
- DiaSorin
- Eurofins Scientific
- QIAGEN
- QuantuMDx Group
- Siemens Healthineers
For more information about this report visit https://www.researchandmarkets.com/r/d7ffsc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
